Where Will Veeva Systems Be in 5 Years?
Shares of life sciences technologist and software provider Veeva Systems (NYSE: VEEV) have been a big winner for the last few years. They've gained 400% over the last five-year stretch, and owning them has been one of the best ways to play the pharmaceuticals and biotech industry.
Even after an epic run, Veeva continues to put up solid double-digit sales growth and even faster profitability expansion, and the cloud-based software firm also reached a revenue milestone well ahead of schedule. On the heels of a recent software stock pullback and with digital transformation taking center stage, now looks like a good time to buy in or add to positions. There will be plenty of ways for Veeva Systems to grow even more in the next five years.
Veeva provides various cloud-delivered software services like data management, regulatory compliance tools, and customer relationship management for pharmaceutical and biotech companies. Biotech is fraught with unique challenges that make the industry especially volatile, and Veeva has been a comparatively stable way to invest in the space.
Source Fool.com
